James Corbett - 12 Dec 2022 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
CEO, Director
Signature
/s/ Donna Shiroma, by power of attorney
Issuer symbol
RCEL
Transactions as of
12 Dec 2022
Net transactions value
$0
Form type
4
Filing time
14 Dec 2022, 16:23:54 UTC
Previous filing
27 Dec 2021
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +226,296 $0.000000 226,296 12 Dec 2022 Common Stock 226,296 $5.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Stock Options were previously granted pursuant to the Reporting Person's Employment Agreement, dated September 26, 2022 and effective September 28, 2022, subject to stockholder approval. On December 12, 2022, the Issuer's stockholders approved the grant of the Stock Options at the Issuer's annual meeting.
F2 These Stock Options vest in four equal annual installments beginning on September 28, 2023.